发明名称 FIBROSIS INHIBITOR FOR IMPLANTED ORGAN
摘要 PROBLEM TO BE SOLVED: To provide a medicine for a transplant patient to which an immunosuppressant is administered for a long time, wherein the medicine inhibits gradual fibrosing of an implanted organ to induce organ dysfunction, and to provide an immunological tolerance acquiring agent for a patient to acquire immunological tolerance to organ rejection when the patient, who is a recipient, is provided with an organ from a donor. SOLUTION: There is provided a fibrosis inhibitor for an implanted organ with administration of an immunosuppressant, which contains a hepatocyte growth factor (HGF). Preferably the hepatocyte growth factor is a peptide containing an amino acid sequence represented by the sequence number 1 or 2, a peptide containing an amino acid sequence which is substantially identical with the amino acid sequence represented by the sequence number 1 or 2 and acting as HGF, or a peptide which is part of the peptides and acts as HGF. COPYRIGHT: (C)2011,JPO&INPIT
申请公布号 JP2011173900(A) 申请公布日期 2011.09.08
申请号 JP20110086165 申请日期 2011.04.08
申请人 KRINGLE PHARMA INC 发明人 AMANO JUN;ITO KENICHI;YAMAURA KAZUHIRO;MATSUMOTO KUNIO;NAKAMURA TOSHIICHI
分类号 A61K38/22;A61P41/00;C07K14/475;C12N15/09 主分类号 A61K38/22
代理机构 代理人
主权项
地址